|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
GlycoFi, Inc. Signs Research Collaboration With Centocor, Inc. (JNJ) To Evaluate The Expression Of Two Proteins
10/19/2005 5:13:16 PM
LEBANON, N.H.--(BUSINESS WIRE)--April 13, 2005--GlycoFi announced today that they initiated a collaboration with Centocor, Inc, to determine the feasibility of producing a Centocor protein using GlycoFi's proprietary yeast-based glycoprotein production technology. Under the agreement, Centocor has the option to use the GlycoFi-yeast based production system for future protein expression in return for milestone payments and royalties to GlycoFi. Financial details were not disclosed. In an on-going research study funded by Centocor, GlycoFi and Centocor are also evaluating the use of GlycoFi technology for the production of an undisclosed Centocor antibody. These two collaborations combine GlycoFi's unique expression technology for the production of human glycoproteins, including antibodies, with Centocor's expertise in the area of therapeutic proteins.
|
|
|
|
|
|
|
|
|
|
|